Stem Cell Pharmaceuticals Inc.
This article was originally published in Start Up
Executive Summary
Stem Cell Pharmaceuticals has several composition of matter and use patents on members of a family of growth factors that cause resident adult stem cells to proliferate, migrate to a site of injury, and differentiate into the type of cell that's needed. It aims to develop an injectable drug that will enhance a patient's own stem cell-based repair mechanisms, providing a therapy that is much safer and easier to administer than stem cell transplantation, company founders believe.